Article info

Download PDFPDF
Two-year cost-effectiveness of different COBRA-like intensive remission induction schemes in early rheumatoid arthritis: a piggyback study on the pragmatic randomised controlled CareRA trial

Authors

  • Sofia Pazmino Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Flanders, Belgium PubMed articlesGoogle scholar articles
  • Annelies Boonen Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, Maastricht, The Netherlands Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands PubMed articlesGoogle scholar articles
  • Veerle Stouten Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Flanders, Belgium PubMed articlesGoogle scholar articles
  • Diederik De Cock Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Flanders, Belgium PubMed articlesGoogle scholar articles
  • Johan Joly Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  • Kristien Van der Elst Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  • Rene Westhovens Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Flanders, Belgium Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  • Patrick Verschueren Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Flanders, Belgium Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Sofia Pazmino, Department of Development and Regeneration, Skeletal Biology and Engineering Research Center, KU Leuven, Leuven B-3000, Belgium; sofia.pazmino{at}kuleuven.be
View Full Text

Citation

Pazmino S, Boonen A, Stouten V, et al
Two-year cost-effectiveness of different COBRA-like intensive remission induction schemes in early rheumatoid arthritis: a piggyback study on the pragmatic randomised controlled CareRA trial

Publication history

  • Received December 23, 2019
  • Revised February 17, 2020
  • Accepted March 1, 2020
  • First published April 2, 2020.
Online issue publication 
April 15, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.